Table 2.
List of peptides identified from tumor-associated antigens
Gene name (protein name) | Peptide sequence | FM-82 | FM-93/2 | Mel-624 | MeWo | SK-Mel-5 | HLA Alleles (IC50 in nM by NetMHCpan 2.8) |
---|---|---|---|---|---|---|---|
SEPT2 (septin-2) | KVNIVPVIAK | X | A*03:01 (46 nM) | ||||
RLYPWGVVEV | X | X | X | A*02:01 (5 nM) | |||
VEIEERGVKL | X | X | B*40:01 (47 nM) | ||||
YIDEQFERY | X | A*01:01 (12 nM) | |||||
ALDH1A1 (retinal dehydrogenase 1) | ASERGRLLY | X | A*01:01 (35 nM) | ||||
TMESMNGGKLY | X | No binding predicted | |||||
ARL4D (ADP-ribosylation factor-like protein 4D) | RLYEMILKR | X | A*03:01 (51 nM) | ||||
ATIC (IMP cyclohydrolase) | NLYPFVKTV | X | X | A*02:01 (41 nM) | |||
BCAP31 (B-cell receptor-associated protein 31) | KLDVGNAEV | X | X | X | X | X | A*02:01 (27 nM) |
CCNB1 (G2/mitotic-specific cyclin-B1) | VMVNQGLTKHMTV | X | A*02:01 (93 nM) | ||||
VVMVNQGLTK | X | X | A*11:01 (27 nM), A*03:01 (95 nM) | ||||
GEVDVEQHTL | X | X | B*40:01 (10 nM) | ||||
TLAKYLMEL | X | X | X | X | A*02:01 (7 nM) | ||
CCND1 (G1/S-specific cyclin-D1) | ALLESSLRQA | X | X | X | A*02:01 (90 nM) | ||
EVFPLAMNY | X | X | A*26:01 (22 nM) | ||||
EVFPLAMNYL | X | A*26:01 (221 nM), C*12:03 (176 nM) | |||||
CCNI (cyclin-I) | AVLTKQLLH | X | No binding predicted | ||||
EVIQWLAKL | X | A*26:01 (11 nM) | |||||
LLDRFLATV | X | X | X | X | A*02:01 (8 nM) | ||
SLLDRFLATV | X | A*02:01 (4 nM) | |||||
CDR2 (cerebellar degeneration-related protein 2) | NSELEQQLGATGAY | X | A*01:01 (67 nM) | ||||
RELEETNQKL | X | X | B*40:01 (19 nM) | ||||
CEP55 (centrosomal protein of 55 kDa) | AELESKTNTL | X | B*40:01 (34 nM) | ||||
EVHNLNQLLY | X | X | A*26:01 (22 nM) | ||||
CPSF1 (cleavage and polyadenylation specificity factor subunit 1) | ALDEKLLNI | X | A*02:01 (47 nM) | ||||
RLGNSLLLK | X | A*03:01 (17 nM) | |||||
TLITDGMRSV | X | X | A*02:01 (76 nM) | ||||
VSDRDRNLMVY | X | A*01:01 (13 nM) | |||||
CSPG4 (chondroitin sulfate proteoglycan 4) | ALTDIDLQL | X | A*02:01 (62 nM) | ||||
ASSSAGTDPQLLLY | X | A*01:01 (39 nM) | |||||
SSSAGTDPQLLLY | X | A*01:01 (14 nM) | |||||
STDPQHHAY | X | A*01:01 (5 nM) | |||||
TMLARLASA | X | X | X | A*02:01 (44 nM), B*08:01 (40 nM) | |||
TPNPALKNGQYW | X | No binding predicted | |||||
DCT (l-dopachrome tautomerase) | ELAPIGHNRMY | X | A*26:01 (50 nM) | ||||
ETHLSSKRY | X | X | A*26:01 (207 nM) | ||||
GTYEGLLRR | X | X | A*03:01 (421 nM), A*11:01 (56 nM) | ||||
KELPSLHVL | X | B*40:01 (18 nM) | |||||
LMETHLSSK | X | A*03:01 (122 nM) | |||||
MTVDSLVNK | X | A*11:01 (9 nM) | |||||
REQFLGALDL | X | X | B*40:01 (13 nM) | ||||
SLDDYNHLV | X | A*02:01 (4 nM) | |||||
SLDDYNHLVTL | X | X | X | A*02:01 (10 nM) | |||
TRPWSGPYIL | X | C*07:02 (182 nM) | |||||
TSDQLGYSY | X | A*01:01 (8 nM) | |||||
VEETPGWPTTL | X | X | B*40:01 (61 nM) | ||||
YYSVRDTLL | X | C*07:02 (57 nM) | |||||
EHD2 (EH domain-containing protein 2) | ALASHLIEA | X | X | X | A*02:01 (6 nM) | ||
GQYSTGKTSFIQY | X | B*15:01 (40 nM) | |||||
KLPNSVLGR | X | No binding predicted | |||||
RVHAYIISY | X | A*03:01 (59 nM) | |||||
ENAH (protein enabled homolog) | ERLERQERL | X | No binding predicted | ||||
GAGE12I (G antigen 12I) | YYWPRPRRY | X | No binding predicted | ||||
GPR143 (G-protein-coupled receptor 143) | ATSPPASVR | X | X | A*11:01 (103 nM) | |||
AVASLLKGR | X | No binding predicted | |||||
GLSTILLYH | X | A*03:01 (390 nM) | |||||
HAIPHYVTM | X | X | X | C*03:03 (5 nM), C*03:04 (5 nM) | |||
MLYYPSVSR | X | A*03:01 (29 nM) | |||||
HMMR (hyaluronan mediated motility receptor) | KLLEYIEEI | X | X | A*02:01 (2 nM) | |||
KLQEELNKV | X | X | A*02:01 (12 nM) | ||||
RLNAALREK | X | A*03:01 (62 nM) | |||||
HMOX1 (heme oxygenase 1) | EVIPYTPAM | X | X | A*26:01 (5 nM) | |||
EVIPYTPAMQR | X | No binding predicted | |||||
EVIPYTPAMQRY | X | A*26:01 (4 nM) | |||||
HNRNPL (heterogeneous nuclear ribonucleoprotein L) | AAAGGGGGGGRY | X | X | No binding predicted | |||
AAAGGGGGGGRYY | X | B*15:01 (159 nM) | |||||
ETLGFLNHY | X | A*26:01 (14 nM) | |||||
KQPAIMPGQSY | X | B*15:01 (98 nM) | |||||
KSDALETLGFLNHY | X | No binding predicted | |||||
MAAAGGGGGGGRY | X | X | X | A*26:01 (170 nM), B*15:01 (59 nM) | |||
YAVDRAITH | X | X | C*12:03 (59 nM), C*03:04 (273 nM) | ||||
HSPA1L (heat-shock 70 kDa protein 1-like) | LIFDLGGGTFD | X | No binding predicted | ||||
TVFDAKRLIGR | X | X | A*11:01 (109 nM) | ||||
DTERLIGDAAKNQV | X | No binding predicted | |||||
RLIGDAAKNQV | X | X | X | X | X | A*02:01 (84 nM) | |
AMTKDNNLL | X | X | No binding predicted | ||||
IGF2BP3 (insulin-like growth factor 2 mRNA-binding protein 3) | EVLDSLLVQY | X | A*26:01 (47 nM) | ||||
KIQEILTQV | X | X | X | X | A*02:01 (21 nM) | ||
TLYNPERTITV | X | X | A*02:01 (80 nM) | ||||
IL13RA2 (interleukin-13 receptor subunit alpha-2) | LLDTNYNLF | X | No binding predicted | ||||
LLDTNYNLFY | X | A*01:01 (10 nM) | |||||
KDM5B (lysine-specific demethylase 5B) | ALKDSVQRA | X | X | No binding predicted | |||
RLIDLGVGL | X | A*02:01 (20 nM) | |||||
RQFVTQLY | X | B*15:01 (30 nM) | |||||
SVAQQLLNGK | X | A*03:01 (20 nM) | |||||
KIF20A (kinesin-like protein KIF20A) | KEAGNINTSL | X | B*40:01 (14 nM) | ||||
RVFQGFFTGR | X | X | A*11:01 (22 nM), A*03:01 (72 nM) | ||||
SEHLDTQKELL | X | B*40:01 (80 nM) | |||||
LGALS3BP (galectin-3-binding protein) | ALWKEPGSNV | X | A*02:01 (42 nM) | ||||
NLWDLTDASVV | X | A*02:01 (19 nM) | |||||
RIDITLSSV | X | A*02:01 (179 nM) | |||||
MAGEA1 (melanoma-associated antigen 1) | ALREEEEGV | X | No binding predicted | ||||
EADPTGHSY | X | A*01:01 (79 nM) | |||||
EVYDGREHSA | X | No binding predicted | |||||
KEADPTGHSY | X | No binding predicted | |||||
KVLEYVIKV | X | A*02:01 (5 nM) | |||||
LTQDLVQEKYLEY | X | A*01:01 (42 nM) | |||||
SAYGEPRKL | X | C*03:04 (184 nM) | |||||
MAGEA12 (melanoma-associated antigen 12) | EVVRIGHLY | X | A*26:01 (7 nM) | ||||
KMAELVHFL | X | X | X | A*02:01 (2 nM) | |||
MAGEA12; MAGEA6; MAGEA3 (melanoma-associated antigen 12; 6; 3) | KIWEELSVLE | X | No binding predicted | ||||
MAGEA2 (melanoma-associated antigen 2) | EVFEGREDSVF | X | X | A*26:01 (72 nM) | |||
MAGEA2; MAGEA2B (melanoma-associated antigen 2; 2B) | KMVELVHFL | X | A*02:01 (2 nM) | ||||
MAGEA1; MAGEA2; MAGEA2B; MAGEA3; MAGEA6 (melanoma-associated antigen 1; 2; 2B; 3; 6) | REPVTKAEML | X | B*40:01 (255 nM) | ||||
MAGEA3 (melanoma-associated antigen 3) | EVDPIGHLYIF | X | No binding predicted | ||||
MAGEA4 (melanoma-associated antigen 4) | GVYDGREHTV | X | A*02:01 (225 nM) | ||||
MAGEA4; MAGEA8 (melanoma-associated antigen 4; 8) | KVLEHVVRV | X | A*02:01 (9 nM) | ||||
MAGEA3; MAGE6 (melanoma-associated antigen 3; 6) | KIWEELSVLEV | X | X | A*02:01 (7 nM) | |||
MAGEC2 (melanoma-associated antigen C2) | ALIEVGPDHFC | X | No binding predicted | ||||
MDM2 (E3 ubiquitin–protein ligase Mdm2) | RLYDEKQQHI | X | A*02:01 (72 nM) | ||||
RLYDEKQQHIVY | X | B*15:01 (54 nM) | |||||
MET (hepatocyte growth factor receptor) | EVIGRGHFGCVY | X | A*26:01 (6 nM) | ||||
KSEMNVNMKY | X | A*01:01 (193 nM) | |||||
MFGE8 (lactadherin) | EVRGDVFPSY | X | A*26:01 (15 nM) | ||||
MLANA (melanoma antigen recognized by T cells 1) | AEEAAGIGIL | X | B*40:01 (9 nM) | ||||
ALMDKSLHV | X | A*02:01 (4 nM) | |||||
MMP2 (72 kDa type IV collagenase; PEX) | AVVDLQGGGHSY | X | X | A*26:01 (232 nM) | |||
NELFA (negative elongation factor A) | KLLDISELDMV | X | X | X | A*02:01 (4 nM) | ||
NOB1 (RNA-binding protein NOB1) | ALQDIGKNIYTI | X | A*02:01 (59 nM) | ||||
NPM1 (nucleophosmin) | DIKAKMQAS | X | No binding predicted | ||||
FEITPPVVL | X | X | B*40:01 (10 nM) | ||||
KMQASIEKA | X | X | A*02:01 (472 nM) | ||||
RMTDQEAIQ | X | X | No binding predicted | ||||
RMTDQEAIQDL | X | X | X | X | A*02:01 (347 nM) | ||
YEGSPIKVTL | X | X | B*40:01 (24 nM) | ||||
NUDCD1 (NudC domain-containing protein 1) | AEEHSIATL | X | B*40:01 (13 nM) | ||||
NUF2 (kinetochore protein Nuf2) | ATAQFKINK | X | A*11:01 (11 nM) | ||||
EVVEKYEIY | X | A*26:01 (9 nM) | |||||
KIDEKTAELK | X | No binding predicted | |||||
OCA2 (P protein) | HVDSTLLQ | X | No binding predicted | ||||
HVDSTLLQV | X | X | X | X | A*02:01 (170 nM) | ||
KEPSEIVEL | X | B*40:01 (104 nM) | |||||
PASD1 (PAS domain-containing protein 1) | QLEERTWLL | X | A*02:01 (79 nM) | ||||
PGK1 (phosphoglycerate kinase 1) | DNGAKSVVL | X | No binding predicted | ||||
EGKVLPGVDALSNI | X | No binding predicted | |||||
PLIN2 (perilipin-2) | RAYQQALSR | X | A*03:01 (140 nM) | ||||
SLLTSSKGQLQK | X | A*03:01 (53 nM) | |||||
SVASTITGV | X | A*02:01 (55 nM) | |||||
TLLSNIQGV | X | A*02:01 (9 nM) | |||||
TSALPIIQK | X | A*11:01 (24 nM) | |||||
PMEL (melanocyte protein PMEL; M-alpha; M-beta) | ALDGGNKHFL | X | X | X | X | X | A*02:01 (168 nM) |
ALLAVGATK | X | A*03:01 (45 nM) | |||||
ALNFPGSQK | X | A*03:01 (21 nM) | |||||
AMLGTHTMEV | X | X | X | X | X | A*02:01 (8 nM) | |
AMLGTHTMEVTV | X | X | A*02:01 (20 nM) | ||||
ASLIYRRRLMK | X | A*11:01 (61 nM) | |||||
FALQLHDPSGY | X | C*03:04 (250 nM) | |||||
FTITDQVPFSVSVSQLR | X | No binding predicted | |||||
GTATLRLVK | X | X | A*11:01 (22 nM), A*03:01 (121 nM) | ||||
HQILKGGSGTY | X | B*15:01 (25 nM) | |||||
HSSSHWLRLP | X | X | No binding predicted | ||||
HTYLEPGPVTAQ | X | No binding predicted | |||||
ITDQVPFSV | X | C*05:01 (37 nM), A*02:01 (188 nM) | |||||
ITDQVPFSVSVSQLR | X | No binding predicted | |||||
KQDFSVPQL | X | A*02:01 (455 nM) | |||||
KTWDQVPFS | X | No binding predicted | |||||
KTWDQVPFSV | X | X | X | X | X | A*02:01 (11 nM) | |
KTWDQVPFSVSV | X | A*02:01 (13 nM) | |||||
KTWGQYWQ | X | No binding predicted | |||||
KTWGQYWQV | X | X | X | X | X | A*02:01 (10 nM) | |
LSIGTGRAM | X | X | C*03:03 (39 nM), C*03:04 (39 nM) | ||||
LVLKRCLLH | X | No binding predicted | |||||
MLGTHTMEV | X | X | X | X | A*02:01 (8 nM) | ||
RNQPLTFALQLHDPSGY | X | No binding predicted | |||||
RYGSFSVTL | X | C*07:02 (362 nM) | |||||
SLADTNSLAV | X | A*02:01 (13 nM) | |||||
SLADTNSLAVV | X | X | X | X | X | A*02:01 (12 nM) | |
SVPQLPHSSSHW | X | No binding predicted | |||||
TITDQVPFSVSVSQLR | X | No binding predicted | |||||
VLYRYGSFSV | X | X | A*02:01 (6 nM) | ||||
VLYRYGSFSVTL | X | A*02:01 (41 nM) | |||||
YRYGSFSVTL | X | X | C*07:01 (10 nM), C*03:03 126 (nM) | ||||
PPIB (peptidyl-prolyl cis–trans isomerase B) | LLLPGPSAA | X | X | X | X | A*02:01 (75 nM) | |
PRAME (MELANOMA antigen preferentially expressed in tumors) | AAFDGRHSQTL | X | X | X | X | C*03:03 (7 nM), C*03:04 (7 nM), C*12:03 (16 nM) | |
ALLERASATL | X | A*02:01 (25 nM) | |||||
ALLPSLSHC | X | X | No binding predicted | ||||
GQHLHLETF | X | B*15:01 (96 nM) | |||||
QLLALLPSL | X | A*02:01 (9 nM) | |||||
RLDQLLRHV | X | X | X | X | A*02:01 (217 nM) | ||
RLVELAGQSLLK | X | A*03:01 (35 nM) | |||||
SLLQHLIGL | X | X | A*02:01 (12 nM) | ||||
YEDIHGTLHL | X | B*40:01 (15 nM) | |||||
PRDX5 (peroxiredoxin-5, mitochondrial) | LLDDSLVSI | X | A*02:01 (8 nM) | ||||
RAN (GTP-binding nuclear protein Ran) | AQYEHDLEVA | X | A*02:01 (303 nM) | ||||
KLIGDPNLEFV | X | X | A*02:01 (5 nM) | ||||
RHOC (Rho-related GTP-binding protein RhoC) | FSIDSPDSL | X | C*03:04 (6 nM) | ||||
IEVDGKQVEL | X | X | B*40:01 (29 nM) | ||||
RPA1 (replication protein A 70 kDa DNA-binding subunit) | DTEFPNFKY | X | A*01:01 (410 nM) | ||||
EVFQNANFRSF | X | A*26:01 (43 nM) | |||||
GAIAAIMQK | X | A*11:01 (32 nM) | |||||
KAYGASKTFGK | X | X | A*03:01 (32 nM), A*11:01 (35 nM) | ||||
KVIDQQNGL | X | No binding predicted | |||||
SGMGSTVSK | X | A*11:01 (31 nM) | |||||
VSDFGGRSL | X | X | X | X | X | C*03:03 (438 nM), C*03:04 (438 nM), C*05:01 (89 nM) | |
RPL10A (replication protein A 70 kDa DNA-binding subunit) | FLASESLIKQI | X | X | X | X | A*02:01 (22 nM) | |
NMVAKVDEV | X | X | X | X | A*02:01 (51 nM) | ||
RILGPGLNK | X | A*03:01 (21 nM) | |||||
SLIKQIPRI | X | X | X | A*02:01 (36 nM) | |||
STIKFQMKK | X | A*11:01 (5 nM) | |||||
TLYEAVREV | X | X | A*02:01 (9 nM) | ||||
RPL19 (60S ribosomal protein L19) | HMYHSLYLK | X | A*03:01 (7 nM) | ||||
ILMEHIHKL | X | X | X | X | X | A*02:01 (2 nM) | |
ILMEHIHKLK | X | A*03:01 37 (nM) | |||||
ILMEHIHKLKA | X | A*02:01 (19 nM) | |||||
KLIKDGLIIRK | X | A*03:01 (49 nM) | |||||
RILMEHIHKLK | X | A*03:01 (90 nM) | |||||
RLASSVLRCGK | X | A*03:01 (23 nM) | |||||
WLDPNETNEI | X | A*02:01 (79 nM) | |||||
RPS2 (40S ribosomal protein S2) | KEWMPVTKL | X | B*40:01 (28 nM) | ||||
RPSA (40S ribosomal protein SA) | NTDSPLRY | X | A*01:01 (7 nM) | ||||
SART1 (U4/U6.U5 tri-snRNP-associated protein 1) | GLLETTVQKV | X | X | A*02:01 (9 nM) | |||
KSMNANTITK | X | X | A*03:01 (61 nM), A*11:01 (12 nM) | ||||
RVKAPNKSL | X | No binding predicted | |||||
SFMBT1 (Scm-like with four MBT domains protein 1) | ESVMINGKY | X | A*26:01 (41 nM) | ||||
SSDNYEHWLY | X | A*01:01 (5 nM) | |||||
SH3GLB2 (endophilin-B2) | EVAPPASGTR | X | No binding predicted | ||||
SOX10 (transcription factor SOX-10) | ETAGPQGPPHY | X | X | A*26:01 (13 nM) | |||
EVMSNMETF | X | A*26:01 (14 nM) | |||||
FSYMGPSQRPL | X | X | X | C*03:03 (3 nM), C*03:04 (3 nM) | |||
GTAAIQAHY | X | X | No binding predicted | ||||
ISKPPGVAL | X | X | C*03:04 (228 nM), C*12:03 (152 nM) | ||||
YGHSGQASGLY | X | No binding predicted | |||||
YSDHQPSGPYY | X | A*01:01 (5 nM) | |||||
YTDQPSTSQIAY | X | A*01:01 (4 nM) | |||||
KLADQYPHL | X | X | A*02:01 (6 nM) | ||||
KTLGKLWRL | X | X | X | A*02:01 (74 nM) | |||
STAT1 (signal transducer and activator of transcription 1-alpha/beta) | ALLKDQQPGTFLL | X | A*02:01 (22 nM) | ||||
DSFPMEIRQY | X | X | No binding predicted | ||||
DSFPMEIRQYL | X | No binding predicted | |||||
EVVHKIIEL | X | A*26:01 (211 nM) | |||||
KLQELNYNL | X | X | X | A*02:01 (6 nM) | |||
QQLDSKFLEQV | X | X | A*02:01 (176 nM) | ||||
VLWDRTFSL | X | X | X | X | A*02:01 (3 nM) | ||
VMLDKQKEL | X | A*02:01 (201 nM) | |||||
SUGT1 (suppressor of G2 allele of SKP1 homolog) | ETFTEGQKL | X | No binding predicted | ||||
TOP2A (DNA topoisomerase 2-alpha) | KLAEAERVGLHK | X | A*03:01 (59 nM) | ||||
KLDETGNSL | X | X | X | A*02:01 (68 nM) | |||
KLDETGNSLK | X | A*03:01 (153 nM) | |||||
KLDETGNSLKV | X | A*02:01 (29 nM) | |||||
SLDKDIVAL | X | A*02:01 (59 nM) | |||||
THFPDETEI | X | B*38:01 (175 nM) | |||||
AEINNIIKI | X | X | B*40:01 (58 nM) | ||||
EVTFVPGLY | X | A*26:01 (12 nM) | |||||
FLYDDNQRV | X | X | X | X | A*02:01 (4 nM) | ||
KIFDEILVNA | X | A*02:01 (26 nM) | |||||
LTYNDFINK | X | A*11:01 (8 nM) | |||||
TP53 (cellular tumor antigen p53) | GLAPPQHLIRV | X | A*02:01 (18 nM) | ||||
TTK (dual specificity protein kinase TTK) | ESFSGSLGHL | X | No binding predicted | ||||
TYMS (thymidylate synthase) | NSELSCQ | X | No binding predicted | ||||
NSELSCQLY | X | A*01:01 (36 nM) | |||||
YMIAHITGL | X | X | A*02:01 (3 nM) | ||||
TYR (tyrosinase) | EEYNSHQSL | X | X | B*40:01 (42 nM) | |||
EVYPEANAPIGHN | X | No binding predicted | |||||
HTISSDYVIPIGTY | X | A*26:01 (18 nM) | |||||
KQLPEEKQPLL | X | X | No binding predicted | ||||
LEEYNSHQSL | X | X | B*40:01 (47 nM) | ||||
LLMEKEDYHSL | X | X | X | X | X | A*02:01 (6 nM) | |
MEKEDYHSL | X | B*40:01 (69 nM) | |||||
NIFDLSAPEKDKFFA | X | A*02:01 (71 nM) | |||||
SSDYVIPIGTY | X | A*01:01 (23 nM) | |||||
YVIPIGTYGQM | X | A*26:01 (37 nM) | |||||
WNK2 (serine/threonine protein kinase WNK2) | HTRTPPIIHR | X | No binding predicted |